Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra D Bunner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Human Neuroscience|July 23, 2016
Corticostriatal Dysfunction in Huntington's Disease: The BasicsKendra D Bunner, George V Rebec
Brain Research Bulletin|February 5, 2022
Measuring movement in health and diseaseGeorge V Rebec, David M Koceja, Kendra D Bunner
The European Journal of Neuroscience|April 3, 2016
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoidsDan P Covey, Kendra D Bunner, Douglas R Schuweiler, et al.
Journal of Neurochemistry|February 16, 2012
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's diseaseBenjamin R Miller, Jenelle L Dorner, Kendra D Bunner, et al.
Plos Computational Biology|April 18, 2020
Striatal network modeling in Huntington's DiseaseAdam Ponzi, Scott J Barton, Kendra D Bunner, et al.
Addiction Biology|August 24, 2022
Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in ratsIdaira Oliva, Shahin A Saberi, Claudia Rangel-Barajas, et al.
Nucleic Acids Research|August 19, 2020
Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systemsNancy V N Carullo, Robert A Phillips Iii, Rhiana C Simon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Human Neuroscience|July 23, 2016
Corticostriatal Dysfunction in Huntington's Disease: The BasicsKendra D Bunner, George V Rebec
Brain Research Bulletin|February 5, 2022
Measuring movement in health and diseaseGeorge V Rebec, David M Koceja, Kendra D Bunner
The European Journal of Neuroscience|April 3, 2016
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoidsDan P Covey, Kendra D Bunner, Douglas R Schuweiler, et al.
Journal of Neurochemistry|February 16, 2012
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's diseaseBenjamin R Miller, Jenelle L Dorner, Kendra D Bunner, et al.
Plos Computational Biology|April 18, 2020
Striatal network modeling in Huntington's DiseaseAdam Ponzi, Scott J Barton, Kendra D Bunner, et al.
Addiction Biology|August 24, 2022
Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in ratsIdaira Oliva, Shahin A Saberi, Claudia Rangel-Barajas, et al.
Nucleic Acids Research|August 19, 2020
Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systemsNancy V N Carullo, Robert A Phillips Iii, Rhiana C Simon, et al.
Pageof 1